Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of financial burden of cancer on survivors' quality of life.
Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, Hofstatter EW, Killelea BK, Knobf MT, Lannin DR, Abu-Khalaf M, Horowitz NR, Chagpar AB. Fenn KM, et al. Among authors: digiovanna mp. J Oncol Pract. 2014 Sep;10(5):332-8. doi: 10.1200/JOP.2013.001322. Epub 2014 May 27. J Oncol Pract. 2014. PMID: 24865220
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.
Abu-Khalaf MM, Windsor S, Ebisu K, Salikooti S, Ananthanarayanan G, Chung GG, DiGiovanna MP, Haffty BG, Abrams M, Farber LR, Hsu AD, Reiss M, Zelterman D, Burtness BA. Abu-Khalaf MM, et al. Among authors: digiovanna mp. Oncology. 2005;69(5):372-83. doi: 10.1159/000089991. Epub 2005 Nov 24. Oncology. 2005. PMID: 16319508 Clinical Trial.
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
Abu-Khalaf MM, Juneja V, Chung GG, DiGiovanna MP, Sipples R, McGurk M, Zelterman D, Haffty B, Reiss M, Wackers FJ, Lee FA, Burtness BA. Abu-Khalaf MM, et al. Among authors: digiovanna mp. Breast Cancer Res Treat. 2007 Sep;104(3):341-9. doi: 10.1007/s10549-006-9413-7. Epub 2006 Oct 19. Breast Cancer Res Treat. 2007. PMID: 17051423
Breast sentinel lymph node dissection before preoperative chemotherapy.
Grube BJ, Christy CJ, Black D, Martel M, Harris L, Weidhaas J, Digiovanna MP, Chung G, Abu-Khalaf MM, Miller KD, Higgins SA, Philpotts L, Tavassoli FA, Lannin DR. Grube BJ, et al. Among authors: digiovanna mp. Arch Surg. 2008 Jul;143(7):692-9; discussion 699-700. doi: 10.1001/archsurg.143.7.692. Arch Surg. 2008. PMID: 18645113
Self-management and transitions in women with advanced breast cancer.
Schulman-Green D, Bradley EH, Knobf MT, Prigerson H, DiGiovanna MP, McCorkle R. Schulman-Green D, et al. Among authors: digiovanna mp. J Pain Symptom Manage. 2011 Oct;42(4):517-25. doi: 10.1016/j.jpainsymman.2010.12.007. Epub 2011 Mar 27. J Pain Symptom Manage. 2011. PMID: 21444183 Free PMC article.
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy.
Acevedo-Gadea C, Hatzis C, Chung G, Fishbach N, Lezon-Geyda K, Zelterman D, DiGiovanna MP, Harris L, Abu-Khalaf MM. Acevedo-Gadea C, et al. Among authors: digiovanna mp. Breast Cancer Res Treat. 2015 Feb;150(1):157-67. doi: 10.1007/s10549-015-3292-8. Epub 2015 Feb 17. Breast Cancer Res Treat. 2015. PMID: 25687356 Clinical Trial.
64 results